Biomega Group (Bergen, Norway) expanded its biorefining footprint by investing in a brand new greenfield website in Hirtshals, Denmark. The growth will improve manufacturing capability and assist its plans to develop its new Biomega PURE salmon peptide enterprise for the human well being and vitamin market, and facilitate continued progress of its Salmigo vary designed for premium petfood segments.
“Hirtshals, Denmark, is a crucial gateway for salmon into Europe with native volumes rising considerably year-on-year,” mentioned Stig Petersen, CEO at Biomega, in a press launch. “We’re partnering with key native suppliers of high-quality recent salmon components. Biomega has acquired large assist from the native authorities, Hjørring municipality and Hirtshals Harbor administration for the event of the venture. We’re delighted to announce this strategic transfer, involving a double-digit million EUR funding in a brand-new facility, to assist our progress plans in premium human and petfood vitamin functions.”
AMERRA Capital Administration acquired Biomega in 2017 and invested further capital for the execution of this venture alongside Natixis Funding Managers affiliated asset supervisor, Mirova Pure Capital, and a number of other members of the administration group, together with the unique founders of Biomega.
“Biomega has demonstrated important progress previously couple of years, and we’ve got expanded our group significantly in consequence,” Petersen mentioned. “The alternatives for our salmon peptides and oils are in depth and, alongside our gross sales within the premium petfood phase, we will now deal with human vitamin. We’re working with various prospects to commercialize well being and vitamin ideas supported by client market developments and we’re excited by the chance that Hirtshals brings to broaden our enterprise.”